Vimarsana
Biggest News Aggregation in the World

Page 35 - Global Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Program Today - Breaking & Trending Today

Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023 - Vimarsana News

Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023

Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise Ultrasound Renal Denervation system Recor Medical, Inc. ("Recor") and its parent company,

Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023 - Vimarsana News

Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023

Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise Ultrasound Renal Denervation system ...

Life at BU Can Be Scary for International Students. This Mentorship Programs Pairs Up Peers - Vimarsana News

Life at BU Can Be Scary for International Students. This Mentorship Programs Pairs Up Peers

“The whole goal behind the program is to provide incoming international undergraduate students with their first friend, so to speak,” says Kamelia Turcotte.

Source: bu.edu
Investing In Girls and Their Futures - Vimarsana News

Investing In Girls and Their Futures

Investing in girls is not only the right thing to do for girls, it will also have positive impacts on their families, their communities and their societies.

Source: forbes.com
Asthma may be common, but its impact is far from mild - Vimarsana News

Asthma may be common, but its impact is far from mild

Yang Xu, Director of Medical Affairs for Respiratory & Immunology at AstraZeneca UK, explores whether the UK over-relies on SABA inhalers, and how we can do better to improve asthma care and treatment.